Insulin detemir is an effective long-acting human insulin analogue for the treatment of type 1 and 2 diabetes mellitus

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.21, Iss.9, 2005-09, pp. : 1-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Insulin Glargine: A Review of its Therapeutic Use as a Long-Acting Agent for the Management of Type 1 and 2 Diabetes Mellitus

By McKeage K. Goa K.L.

Drugs, Vol. 61, Iss. 11, 2001-01 ,pp. : 1599-1624

Adis International

Access to resources Recommend Favorite

A combination of insulin glargine and rapid-acting insulin analogue (RAIA) is effective for the treatment of children with type 1 diabetes.

Inpharma, Vol. 1, Iss. 1636, 2008-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Insulin Detemir: A Review of its Use in the Management of Type 1 and 2 Diabetes Mellitus

By Therese M. Chapman Caroline M. Perry

Drugs, Vol. 64, Iss. 22, 2004-01 ,pp. : 2577-2595

Adis International

Access to resources Recommend Favorite

Deleterious Outcomes after Abrupt Transition from Insulin Glargine to Insulin Detemir in Patients with Type 1 Diabetes Mellitus

By Kabadi Udaya M.

Clinical Drug Investigation, Vol. 28, Iss. 11, 2008-01 ,pp. : 697-701

Adis International

Access to resources Recommend Favorite

Choice of Long-Acting Insulin Therapy for Type 2 Diabetes: How Can Treatment for Older People be Optimized?

By Krentz Andrew J. Sinclair Alan J.

Drugs & Aging, Vol. 28, Iss. 12, 2011-12 ,pp. : 935-941

Adis International

Access to resources Recommend Favorite